Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
41.55    -1.75 (-4.04%)
Bid:
41.30
Ask:
42.00
Spread: 0.70 (1.695%)
Market Cap: £276.67m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Director Declaration

27 Mar 2017 12:18

RNS Number : 6302A
Derriston Capital PLC
27 March 2017
 

Derriston Capital plc

 

Director Declaration

 

Derriston Capital plc, which has been created to consider opportunities within the global medical technology industry, announces that Harry Hyman, non-executive Chairman, is a non-executive Director of BioPharma Credit plc, which began trading on the London Stock Exchange this morning.

 

For information please contact:

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

lifesciences@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNMMGZFMNVGNZM
Date   Source Headline
4th Jun 20264:30 pmRNSResults of 2026 Annual General Meeting
4th Jun 20267:00 amRNSAGM Statement
13th May 20266:00 pmRNSNotice of AGM
7th May 20267:00 amRNSFirst Quarter Trading Update
30th Apr 20265:00 pmRNSHolding(s) in Company
24th Apr 20265:45 pmRNSAnnual Report and Accounts
15th Apr 20267:00 amRNSNotice of Q1 Trading Update
26th Mar 202612:58 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSAudited 2025 Results
26th Feb 20267:00 amRNSNotice of Results
26th Jan 20267:00 amRNSFourth Quarter Trading Update
1st Dec 20257:00 amRNSTotal Voting Rights
24th Nov 20257:00 amRNSTrading Update
14th Nov 202512:15 pmRNSBoard Changes
6th Nov 20257:01 amRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Trading Update
5th Nov 20257:00 amRNSIssue of Shares
17th Oct 20259:00 amRNSNotice of Q3 Trading Update
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSIssue of Shares
15th Sep 20257:00 amRNSInterim Results for 2025
1st Sep 202511:04 amRNSTotal Voting Rights and Capital
22nd Aug 20257:00 amRNSNotice of Results
15th Aug 20257:00 amRNSIssue of Shares
11th Aug 20257:00 amRNSResponse to Press Speculation
1st Aug 20259:15 amRNSTotal Voting Rights
25th Jul 20257:00 amRNSIssue of Shares
17th Jul 20253:02 pmRNSHolding(s) in Company
3rd Jul 20254:30 pmRNSBoard Change
4th Jun 20253:03 pmRNSResult of AGM
4th Jun 20257:00 amRNSS4 Capital AGM statement
16th May 20253:01 pmRNSDirector/PDMR Shareholding
9th May 20252:30 pmRNSNotice of AGM
8th May 20257:00 amRNSS4 Capital Q1 2025 Trading Update
1st May 20257:00 amRNSBoard Appointments
25th Apr 202511:39 amRNSNotice of Q1 Trading Update
3rd Apr 20259:11 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSAudited 2024 Results
17th Mar 20257:00 amRNSNotice of Results
28th Jan 20257:00 amRNSFourth Quarter Trading Update
9th Jan 20257:00 amRNSManagement Change
2nd Dec 20243:55 pmRNSTotal Voting Rights
15th Nov 20243:30 pmRNSDirector/PDMR Shareholding
15th Nov 20247:00 amRNSIssue of Shares
7th Nov 20247:00 amRNSThird Quarter Trading Update
4th Nov 20247:00 amRNSNotice of Q3 Trading Update
1st Nov 20249:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSIssue of Shares
7th Oct 20247:00 amRNSIssue of Shares
19th Sep 20247:00 amRNSInterim Results for 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.